Wafik El-Deiry Dordaviprone

Wafik El-Deiry: Are We Ready to Reduce Animal Testing in Cancer Drug Development

Wafik El-Deiry, Chair at WIN Consortium in Cancer Personalized Medicine, shared on LinkedIn:

“Are we ready to reduce animal testing in cancer drug development and to require alternatives in each new NIH grant submission?”

Read more.

More posts featuring Wafik El-Deiry.

cancer drug development NIH OncoDaily Oncology Wafik El-Deiry Wafik S. El-Deiry